Newsroom

SAN ANTONIO--(BUSINESS WIRE)--As Americans continue commemorating our nation’s 250th anniversary, The National Military Monument will open to the public on July 28, offering a one-of-a-kind tribute honoring more than 41 million Americans who have answered the call to serve across 250 years of our nation’s history. Located on the steps of the Lincoln Memorial in Washington, D.C., the monument invites visitors to reflect on the generations of Americans whose courage, sacrifice and commitment has...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced changes to its senior leadership team. Alex Kelly, currently Chief Financial Officer, has been promoted to the newly created role of Chief Operating Officer where he will oversee all key customer-facing functions. Naresh Tanna, currently Vice Preside...

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca: Revenue and EPS summary   H1 2026 % Change Q2 2026 % Change   $m Actual CER1 $m Actual CER - Product Sales 28,896 8 5 14,510 5 4 - Alliance Revenue 1,699 31 29 874 34 33 Product Revenue 30,595 9 6 15,384 6 5 Collaboration Revenue 77 (6) (9) - n/m n/m Total Revenue 30,672 9 6 15,384 6 5 Reported EPS ($) 3.60 4 3 1.61 2 (2) Core2 EPS ($) 5.21 12 11 2.63 21 18 Key performance elements for H1 2026 (Growth numbers at constant exchange rates) Total Re...

CHICAGO--(BUSINESS WIRE)--Pure Lithium Corporation, a vertically integrated next-generation lithium metal battery company and developer of the patented Brine to Battery™ technology, today announced the appointment of Dr. Tobias Glossmann as Chief Product Officer. In this role, Dr. Glossmann will lead product and technology strategy, guiding the translation of Pure Lithium’s battery science into engineered products and directing the company’s product engineering efforts. Dr. Glossmann joins Pure...

BOSTON--(BUSINESS WIRE)--Liberate Bio, Inc., a biotechnology company developing genetic medicines that program immune cells directly inside the body, today announced the appointment of Steven H. Bernstein, M.D., as Chief Medical Officer, effective July 13, 2026. Dr. Bernstein joins Liberate as the company advances its myeloid-selective, liver-detargeted lipid nanoparticle platform and lead in vivo CAR-M programs toward first clinical evaluation. In this role, he will lead clinical development s...

NEW YORK--(BUSINESS WIRE)--Global Atlantic, a leading provider of retirement security and investment solutions and a wholly-owned subsidiary of KKR, announced its inclusion in Barron’s annual 100 Best Annuities guide, marking the firm’s fifth consecutive year of recognition. This year's rankings reflect the strength of Global Atlantic’s product lineup and continued focus on delivering innovative retirement products designed to meet the evolving needs of today’s investors. “We are honored to be...

シカゴ--(BUSINESS WIRE)--（ビジネスワイヤ） -- 次世代リチウム金属電池の開発企業であり、特許取得済みの「Brine to Battery™」技術を開発した垂直統合型企業であるピュア・リチウム・コーポレーションは、トビアス・グロスマン博士を最高製品責任者（CPO）に任命したと発表しました。グロスマン博士は、製品および技術戦略を統括し、ピュア・リチウムの電池技術の製品化を推進するとともに、同社の製品エンジニアリング全般を指揮します。 グロスマン博士は、メルセデス・ベンツ関連企業で25年にわたりキャリアを積み、直近ではメルセデス・ベンツ・リサーチ・アンド・デベロップメント・ノースアメリカのプリンシパル・システムズ・エンジニアを務めました。同氏は、材料開発からバッテリーシステム全体に至るまで、先進バッテリー技術の開発に幅広く携わるとともに、高電圧安全性に関する全社的な責任も担ってきました。同氏は2001年、ドイツ・ウルムのダイムラー・クライスラーでバッテリーシステム開発に従事した後、米国ミシガン州でも同分野の開発に携わり、セル化学、熱モデリング、計算科学、バッテリーシス...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS) (the “Company” or “Gossamer”), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), announced a series of regulatory, strategic, and corporate updates. Following a productive Pre-NDA Type B meeting with the U.S. Food and Drug Administration (FDA)...

CHICAGO--(BUSINESS WIRE)--Pure Lithium Corporation, une entreprise de nouvelle génération et intégrée verticalement spécialisée dans les batteries au lithium-métal, ainsi que la développeuse de la technologie brevetée « Brine to Battery™ », a annoncé aujourd’hui la nomination du Dr Tobias Glossmann au poste de directeur des produits. À ce poste, le Dr Glossmann dirigera la stratégie produit et technologique, pilotera la transformation de la science des batteries de Pure Lithium en en produits t...

CHICAGO--(BUSINESS WIRE)--Pure Lithium Corporation, una empresa de baterías de litio metálico de última generación integrada verticalmente y desarrolladora de la tecnología patentada Brine to Battery™, ha anunciado hoy el nombramiento del Dr. Tobias Glossmann como director de producto. En este cargo, el Dr. Glossmann dirigirá la estrategia de producto y tecnología, orientando la aplicación de los avances científicos de Pure Lithium en materia de baterías a la creación de productos de ingeniería...